Tocqueville Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-667
| Closed | -$2K | – | 772 |
|
|
2018
Q4 | $2K | Hold |
667
| – | – | ﹤0.01% | 739 |
|
|
2018
Q3 | $5K | Hold |
667
| – | – | ﹤0.01% | 811 |
|
|
2018
Q2 | $5K | Hold |
667
| – | – | ﹤0.01% | 820 |
|
|
2018
Q1 | $23K | Hold |
667
| – | – | ﹤0.01% | 819 |
|
|
2017
Q4 | $28K | Hold |
667
| – | – | ﹤0.01% | 790 |
|
|
2017
Q3 | $29K | Hold |
667
| – | – | ﹤0.01% | 801 |
|
|
2017
Q2 | $25K | Hold |
667
| – | – | ﹤0.01% | 780 |
|
|
2017
Q1 | $36K | Hold |
667
| – | – | ﹤0.01% | 791 |
|
|
2016
Q4 | $35K | Hold |
667
| – | – | ﹤0.01% | 794 |
|
|
2016
Q3 | $40K | Hold |
667
| – | – | ﹤0.01% | 814 |
|
|
2016
Q2 | $44K | Hold |
667
| – | – | ﹤0.01% | 826 |
|
|
2016
Q1 | $38K | Sell |
667
-4,226
| -86% | -$241K | ﹤0.01% | 847 |
|
|
2015
Q4 | $1.15M | Buy |
4,893
+1,733
| +55% | +$408K | 0.02% | 514 |
|
|
2015
Q3 | $500K | Sell |
3,160
-73
| -2% | -$11.6K | 0.01% | 696 |
|
|
2015
Q2 | $1.22M | Buy |
3,233
+66
| +2% | +$25K | 0.01% | 534 |
|
|
2015
Q1 | $1.32M | Buy |
3,167
+667
| +27% | +$279K | 0.02% | 540 |
|
|
2014
Q4 | $684K | Buy |
2,500
+580
| +30% | +$159K | 0.01% | 642 |
|
|
2014
Q3 | $373K | Sell |
1,920
-323
| -14% | -$62.7K | ﹤0.01% | 685 |
|
|
2014
Q2 | $549K | Sell |
2,243
-1,080
| -33% | -$264K | 0.01% | 702 |
|
|
2014
Q1 | $881K | Buy |
3,323
+200
| +6% | +$53K | 0.01% | 468 |
|
|
2013
Q4 | $1.13M | Buy |
3,123
+1,430
| +84% | +$519K | 0.02% | 432 |
|
|
2013
Q3 | $900K | Buy |
1,693
+320
| +23% | +$170K | 0.01% | 528 |
|
|
2013
Q2 | $322K | Buy |
+1,373
| New | +$322K | ﹤0.01% | 758 |
|